Analysts' Actions -- AstraZeneca, Credit Suisse, Cubic, Valspar and More
RATINGS CHANGES
AstraZeneca (AZN) - Get Report was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: AZN.
Credit Suisse (CS) - Get Report was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: CS.
Cubic (CUB) - Get Report was upgraded to buy at Benchmark. $58 price target. The transportation and defense businesses can drive a growth turnaround, Benchmark said.
Pattern Energy Group (PEGI) - Get Report was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: PEGI.
Valspar (VAL) - Get Report was downgraded to neutral from overweight at JPMorgan. The valuation is no longer as attractive, based on an $85 price target, JPMorgan said.
Valspar was also downgraded to underperform at RBC Capital Markets. $82 price target. The company is facing increased competition, RBC said.
This article was written by a staff member of TheStreet.